Accredited practising dietitians (apds) can advise your patients on the specific nutritional management of chronic health cond

APD Hotline 1800 812 942
ACCREDITED PRACTISING DIETITIANS
YOUR PROFESSIONAL NUTRITION AND DIETETIC PARTNERS
Website: www.daa.asn.au
Improving patient outcomes through medical nutrition therapy
Accredited Practising Dietitians (APDs) can advise your patients on the specific nutritional management of chronic health conditions. They translate scientific information into individualised and practical dietary advice to assist patients to manage their condition. Nutritional management should be reviewed by an APD periodically. Diagnosis/condition Indication for referral
Benefits of APD involvement
All Disorders
Better understanding of dietary management Change in clinical markers or medication Improved clinical outcome Improved quality of life Improved tolerance to treatments Anaemia –
(Fe deficient)
Chronic fatigue
syndrome
Chronic Obstructive
Pulmonary Disease
Coeliac disease
Poor understanding of nutritional management Congestive Cardiac
Constipation
Coronary Heart Disease
Poor understanding of nutritional a management Mental Health (Anxiety,
Depression, Bipolar,
Schizophrenia)
Reduced risk of heart disease and diabetes Undesirable weight change Medication side-effects (eg. clozapine or olanzapine) Elevated BGLs, insulin or lipid levels Poor food skills (eg. selection and preparation) Diabetes
Poor understanding of nutritional management Changes to medication prescribed Undesirable weight change Diarrhoea
Disability – physical or
Difficulty chewing, swallowing or feeding self Undesirable weight change Diverticulosis /
Diverticulitis
Eating disorders
Poor dietary intake including restrictive dieting Purging, laxative abuse or excessive exercise Weight change or overly concerned with weight Improved eating behaviour Should only be implemented with psychological counselling & support ODY MASS INDEX (BMI) = WEIGHT (KG)/HEIGHT (M)
APD Hotline 1800 812 942
ACCREDITED PRACTISING DIETITIANS
YOUR PROFESSIONAL NUTRITION AND DIETETIC PARTNERS
Website: www.daa.asn.au
Diagnosis/condition
Indication for referral
Benefits of APD involvement
Food allergy or
intolerance
Poor understanding of nutritional management Gastro-oesophageal
General and Gastro
Inadequate oral intake of food and fluid Dietary management of stoma (for colostomy and Better understanding of dietary management of HIV positive
Undesirable weight change Poor food skills (eg. selection and preparation) Hyperlipidaemia/
Prior to or in combination with statin therapy dyslipidaemia
Low HDL-C Poor understanding of nutritional management Hypertension
Elevated systolic and or diastolic blood pressure Inflammatory bowel
(Crohn’s disease,
Poor understanding of nutritional management ulcerative colitis)
Insulin resistance or
Impaired Glucose
Tolerance
Irritable bowel
syndrome
Liver Disease
Encephalopathy Undesirable weight change Metabolic Syndrome
Multiple
sclerosis/Motor
neurone disease
Difficulty feeding self Undesirable weight change Poor food skills (eg. selection and preparation) Support and motivation to make dietary changes Improved medical condition Osteoporosis
Parkinson’s disease
Difficulty feeding self Undesirable weight change Polycystic Ovary
Syndrome
Renal Disease
Elevated urea, creatinine, potassium, phosphate ODY MASS INDEX (BMI) = WEIGHT (KG)/HEIGHT (M)

Source: http://www.rdconsulting.com.au/userimages/OutcomesGP.pdf

utoronto.ca

JAMA -EXPRESS Varenicline, an ␣ 4 ␤ 2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation A Randomized Controlled Trial Context The ␣4␤2 nicotinic acetylcholine receptors (nAChRs) are linked to the re- inforcing effects of nicotine and maintaining smoking behavior. Varenicline, a novel␣4␤2 nAChR partial agoni

Microsoft word - 09_jamieson_comment-on-karpf.docx

Messages, Micro-targeting, and New Media Technologies Final draft of paper to be published in The Forum: A Journal of Applied Research in Contemporary Politics Volume 11, Issue No. 3 (October 2013), p. 429-435. Please note that this is a final draft submitted to The Forum, subject to slight last minute editing by The Forum. Consult the published version for exact quotations. This p

Copyright © 2010 Health Drug Pdf